Revisiting the Mechanisms of CNS Immune Privilege

Trends in Immunology

Volumn 36, Issue 10, 2015, Pages 569-577

  Louveau, Antoine ^a   Harris, Tajie H ^a   Kipnis, Jonathan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID DRAINAGE; CERVICAL LYMPH NODE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHATIC SYSTEM; MENINX; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PARENCHYMA; REVIEW; T LYMPHOCYTE; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; IMMUNOLOGY; LYMPHATIC SYSTEM DISEASE; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNE SYSTEM; LYMPHATIC DISEASES; LYMPHATIC SYSTEM;

EID: 84942518278     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.08.006     Document Type: Review

References (104)

1. Ransohoff R.M., et al. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
2. Engelhardt B., Ransohoff R.M. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012, 33:579-589.
3. Takeshita Y., Ransohoff R.M. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol. Rev. 2012, 248:228-239.
4. Bentivoglio M., Kristensson K. Tryps and trips: cell trafficking across the 100-year-old blood-brain barrier. Trends Neurosci. 2014, 37:325-333.
5. Russi A.E., Brown M.A. The meninges: new therapeutic targets for multiple sclerosis. Transl. Res. J. Lab. Clin. Med. 2015, 165:255-269.
6. Weller R.O. Microscopic morphology and histology of the human meninges. Morphol. Bull. Assoc. Anat. 2005, 89:22-34.
7. Decimo I., et al. Meninges: from protective membrane to stem cell niche. Am. J. Stem Cells 2012, 1:92-105.
8. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012, 12:623-635.
9. Kipnis J., et al. Pro-cognitive properties of T cells. Nat. Rev. Immunol. 2012, 12:663-669.
10. Medawar P.B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 1948, 29:58-69.
11. Cserr H.F., et al. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 1992, 2:269-276.
12. Kida S., et al. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol. Appl. Neurobiol. 1993, 19:480-488.
13. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004, 5:575-581.
14. Walsh J.T., et al. Regulatory T cells in central nervous system injury: a double-edged sword. J. Immunol. 2014, 193:5013-5022.
15. Schwartz M., Raposo C. Protective autoimmunity: a unifying model for the immune network involved in CNS repair. Neuroscientist 2014, 20:343-358.
16. Louveau A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015, 523:337-341.
17. Aspelund A., et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 2015, 212:991-999.
18. Andres K.H., et al. Nerve fibres and their terminals of the dura mater encephali of the rat. Anat. Embryol. (Berl.) 1987, 175:289-301.
19. Shirai Y. On the transplantation of the rat sarcoma in adult heterogeneous animals. Japn Med. World 1921, 1:15.
20. Murphy J.B., Sturm E. Conditions determining the transplantability of tissues in the brain. J. Exp. Med. 1923, 38:183-194.
21. Willis R.A. Experiments on the intracerebral implantation of embryo tissues in rats. Proc. R. Soc. Lond. Ser. B 1935, 117:400-412.
22. Widner H., Brundin P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. 1988, 472:287-324.
23. Harling-Berg C., et al. Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J. Neuroimmunol. 1989, 25:185-193.
24. Foldi M., et al. Über Wirkungen der Unterbindung der Lymphgefasse und Lymphknoten des Halses auf das Zentralnervensystem im Tierversuch. Z. Ges. Exp. Med. 1963, 137:483-510. (in German).
25. Weller R.O., et al. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009, 117:1-14.
26. Laman J.D., Weller R.O. Drainage of cells and soluble antigen from the CNS to regional lymph nodes. J. Neuroimmune Pharmacol. 2013, 8:840-856.
27. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
28. Syková E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88:1277-1340.
29. Groothuis D.R., et al. Efflux of drugs and solutes from brain: the interactive roles of diffusional transcapillary transport, bulk flow and capillary transporters. J. Cereb. Blood Flow Metab. 2007, 27:43-56.
30. Verkman A.S. Diffusion in the extracellular space in brain and tumors. Phys. Biol. 2013, 10:045003.
31. Rennels M.L., et al. Evidence for a "paravascular" fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985, 326:47-63.
32. Rennels M.L., et al. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv. Neurol. 1990, 52:431-439.
33. Szentistványi I., et al. Drainage of interstitial fluid from different regions of rat brain. Am. J. Physiol. 1984, 246:F835-F844.
34. Iliff J.J., et al. A paravascular pathway facilitates CSF Flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 2012, 4:147ra111.
35. Yang L., et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J. Transl. Med. 2013, 11:107.
36. Thrane V.R., et al. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain. Sci. Rep. 2013, 3:2582.
37. Xie L., et al. Sleep drives metabolite clearance from the adult brain. Science 2013, 342:373-377.
38. Kress B.T., et al. Impairment of paravascular clearance pathways in the aging brain. Ann. Neurol. 2014, 76:845-861.
39. Iliff J.J., et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J. Neurosci. 2013, 33:18190-18199.
40. Plog B.A., et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J. Neurosci. 2015, 35:518-526.
41. Iliff J.J., et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J. Neurosci. 2014, 34:16180-16193.
42. Potokar M., et al. Regulation of AQP4 surface expression via vesicle mobility in astrocytes. Glia 2013, 61:917-928.
43. Mohammad M.G., et al. Immune cell trafficking from the brain maintains CNS immune tolerance. J. Clin. Invest. 2014, 124:1228-1241.
44. Whedon J.M., Glassey D. Cerebrospinal fluid stasis and its clinical significance. Altern. Ther. Health Med. 2009, 15:54-60.
45. Kido D.K., et al. Human spinal arachnoid villi and granulations. Neuroradiology 1976, 11:221-228.
46. Go K.G., et al. Fluid secretion in arachnoid cysts as a clue to cerebrospinal fluid absorption at the arachnoid granulation. J. Neurosurg. 1986, 65:642-648.
47. Upton M.L., Weller R.O. The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations. J. Neurosurg. 1985, 63:867-875.
48. Mawera G., Asala S.A. The function of arachnoid villi/granulations revisited. Cent. Afr. J. Med. 1996, 42:281-284.
49. Leach J.L., et al. Normal appearance of arachnoid granulations on contrast-enhanced CT and MR of the brain: differentiation from dural sinus disease. AJNR Am. J. Neuroradiol. 1996, 17:1523-1532.
50. Roche J., Warner D. Arachnoid granulations in the transverse and sigmoid sinuses: CT, MR, and MR angiographic appearance of a normal anatomic variation. AJNR Am. J. Neuroradiol. 1996, 17:677-683.
51. 125I-albumin clearance. Neuropathol. Appl. Neurobiol. 1996, 22:325-333.
52. Tripathi B.J., Tripathi R.C. Vacuolar transcellular channels as a drainage pathway for cerebrospinal fluid. J. Physiol. 1974, 239:195-206.
53. Johnston M., et al. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. 2004, 1:2.
54. Johnston M., et al. Subarachnoid injection of Microfil reveals connections between cerebrospinal fluid and nasal lymphatics in the non-human primate. Neuropathol. Appl. Neurobiol. 2005, 31:632-640.
55. Koh L., et al. Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption?. Cerebrospinal Fluid Res. 2005, 2:6.
56. Weller R.O., et al. Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology 2010, 17:295-306.
57. Johanson C.E., et al. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008, 5:10.
58. Nagra G., et al. Quantification of cerebrospinal fluid transport across the cribriform plate into lymphatics in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1383-R1389.
59. Zhang E.T., et al. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol. 1992, 83:233-239.
60. Goldmann J., et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J. Leukoc. Biol. 2006, 80:797-801.
61. Kaminski M., et al. Migration of monocytes after intracerebral injection at entorhinal cortex lesion site. J. Leukoc. Biol. 2012, 92:31-39.
62. Harris M.G., et al. Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci. Rep. 2014, 4:4422.
63. Thomas S.N., et al. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J. Immunol. 2012, 189:2181-2190.
64. Wekerle H., Sun D. Fragile privileges: autoimmunity in brain and eye. Acta Pharmacol. Sin. 2010, 31:1141-1148.
65. Zamvil S., et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985, 317:355-358.
66. Chen Y., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
67. Kawakami N., et al. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 2005, 201:1805-1814.
68. Prat A., et al. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch. Neurol. 2002, 59:391-397.
69. Prat A., et al. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume. Ann. Neurol. 2000, 47:234-237.
70. Steinman L., Zamvil S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 2005, 26:565-571.
71. Liblau R.S., et al. Neurons as targets for T cells in the nervous system. Trends Neurosci. 2013, 36:315-324.
72. Siffrin V., et al. In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 2010, 33:424-436.
73. Zipp F., et al. Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?. JAMA Neurol. 2013, 70:1569-1574.
74. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
75. McCormack P.L. Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis. Drugs 2013, 73:1463-1481.
76. Steinman L. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat. Rev. Drug Discov. 2005, 4:510-518.
77. Theien B.E., et al. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 2001, 107:995-1006.
78. Steinman L. Immunology of relapse and remission in multiple sclerosis. Annu. Rev. Immunol. 2014, 32:257-281.
79. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
80. Cohen J.N., et al. Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. PLoS ONE 2014, 9:e87740.
81. Rouhani S.J., et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat. Commun. 2015, 6:6771.
82. Tewalt E.F., et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 2012, 120:4772-4782.
83. Malhotra D., et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 2012, 13:499-510.
84. Lund A.W., et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 2012, 1:191-199.
85. Shields J.D., et al. Induction of lymphoid-like stroma and immune escape by tumors that express the chemokine CCL21. Science 2010, 328:749-752.
86. Swanson P.A., McGavern D.B. Viral diseases of the central nervous system. Curr. Opin. Virol. 2015, 11:44-54.
87. +-T-cell expansion and trafficking following central nervous system infection. J. Virol. 2003, 77:2775-2778.
88. Bergmann C.C., et al. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 2006, 4:121-132.
89. McGavern D.B., Kang S.S. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 2011, 11:318-329.
90. Tan I.L., et al. HIV-associated opportunistic infections of the CNS. Lancet Neurol. 2012, 11:605-617.
91. + T cells in the Toxoplasma-infected brain. Semin. Immunopathol. 2015, 37:261-270.
92. Torti N., et al. Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog. 2011, 7:e1002313.
93. Gadani S.P., et al. Dealing with Danger in the CNS: the response of the immune system to injury. Neuron 2015, 87:47-62.
94. Walsh J.T., et al. T cells in the central nervous system: messengers of destruction or purveyors of protection?. Immunology 2014, 141:340-344.
95. Shechter R., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
96. Kroner A., et al. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
97. Evans T.A., et al. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp. Neurol. 2014, 254:109-120.
98. + T cells protect injured CNS neurons via IL-4. J. Clin. Invest. 2015, 125:699-714.
99. Brynskikh A., et al. Adaptive immunity affects learning behavior in mice. Brain. Behav. Immun. 2008, 22:861-869.
100. Derecki N.C., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
101. + T cells are sufficient to support learning behavior in mice with limited T cell repertoire. Brain. Behav. Immun. 2014, 35:58-63.
102. Wolf S.A., et al. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 2009, 182:3979-3984.
103. Marin I., Kipnis J. Learning and memory . . . and the immune system. Learn. Mem. 2013, 20:601-606.
104. Truman L.A., et al. ProxTom Lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets. Am. J. Pathol. 2012, 180:1715-1725.